Dow Chemical has signed over its entire portfolio of intellectual
property and technology in the area of dendrimers - branched
polymers with applications in targetted drug delivery - to US firm
Dendritic NanoTechnologies and Starpharma...
A new European project on the emerging discipline of
nanobiotechnology aims to tackle the thorny issue of safety as well
as develop new materials for drug delivery and other medical uses,
reports Phil Taylor.
TransPharma Medical has entered into collaboration with Teva
Pharmaceutical to develop transdermal drug delivery systems. The
deal aims to research and develop transdermal delivery of
therapeutic drugs such as high molecular weight...
OctoPlus, a drug delivery and development company, and InnoCore
Technologies, a supplier of biodegradable polymeric drug delivery
systems, announced a joint collaboration to develop and market a
novel injectable drug delivery platform.
Australian company pSivida is on the brink of starting clinical
trials of a silicon-based nanomaterial that could find broad
applications across drug and vaccine delivery, diagnostics and
tissue engineering, writes Phil Taylor.
Access Pharmaceuticals has signed an agreement with an unnamed US
partner for a drug delivery system based on nanoparticle aggregates
that can be used to formulate proteins that are degraded by
Researchers in the US have developed a way of self-assembling
liposomes - lipid particles used to carry a drug payload - that are
smaller and more uniform in size than can be achieved using current